Dexmedetomidine produces its neuroprotective effect via the α2A-adrenoceptor subtype

被引:237
作者
Ma, DQ
Hossain, M
Rajakumaraswamy, N
Arshad, M
Sanders, RD
Franks, NP
Maze, M
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Anaesthet, Chelsea & Westminster Hosp, London SW10 9NH, England
[2] Univ London Imperial Coll Sci Technol & Med, Dept Intens Care, Chelsea & Westminster Hosp, London SW10 9NH, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Chelsea & Westminster Hosp, London SW10 9NH, England
基金
英国医学研究理事会;
关键词
neonatal asphyxia; cell culture; alpha(2)-adrenoceptor antagonist; neuronal injury; neurological function;
D O I
10.1016/j.ejphar.2004.08.044
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Which of the three alpha(2)-adrenoceptor subtypes of alpha(2A), alpha(2B), or alpha(2C) mediates the neuroprotective effect of dexmedetomidine was examined in cell culture as well as in an in vivo model of neonatal asphyxia. Dexmedetomidine dose-dependently attenuated neuronal injury (IC50=83 +/- 1 nM) in neuronal-glial co-cultures derived from wild-type mice; contrastingly, dexmedetomidine did not exert neuroprotection in injured cells from transgenic mice (D79N) expressing dysfunctional alpha(2A)-adrenoceptors. An alpha(2A)-adrenoceptor subtype-preferring antagonist 2-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole maleate (BRL44408) completely reversed dexmedetomidine-induced neuroprotection, while other subtype-preferring antagonists 2-[2-(4-(2-Methoxyphenyl)piperazin-1-yl)ethyl]-4,4-dimethyl-1,3-(2H,4H)-isoquinolindione dihydrochloride (ARC239) (alpha(2B)) and rauwolscine (alpha(2C)) had no significant effect on the neuroprotective effect of dexmedetomidine in neuronal-glial co-cultures. Dexmedetomidine also protected against exogenous glutamate induced cell death in pure cortical neuron cultures assessed by flow cytometry and reduced both apoptotic and necrotic types of cell death. Likewise this neuroprotective effect was antagonised by BRL44408 but not ARC239 or rauwolscine. Dexmedetomidine exhibited dose-dependent protection against brain matter loss in vivo (IC50=40.3 +/- 6.1 mug/kg) and improved the neurologic functional deficit induced by the hypoxic-ischemic insult. Protection by dexmedetomidine against hypoxic-ischemic-induced brain matter loss was reversed by the alpha(2A)-adrenoceptor subtype-preferring antagonist BRL44408; neither ARC239 nor rauwolscine reversed the neuroprotective effect of dexmedetomidine in vivo. Our data suggest that the neuroprotective effect of dexmedetomidine is mediated by activation of the alpha(2A) adrenergic receptor subtype. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:87 / 97
页数:11
相关论文
共 60 条
[1]
EVALUATION OF BRAIN-DAMAGE IN A RAT MODEL OF NEONATAL HYPOXIC-ISCHEMIA [J].
ANDINE, P ;
THORDSTEIN, M ;
KJELLMER, I ;
NORDBORG, C ;
THIRINGER, K ;
WENNBERG, E ;
HAGBERG, H .
JOURNAL OF NEUROSCIENCE METHODS, 1990, 35 (03) :253-260
[2]
α2A- but not α2B/C-adrenoceptors modulate noradrenaline release in rat locus coeruleus:: voltammetric data [J].
Callado, LF ;
Stamford, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 366 (01) :35-39
[3]
Hyperbaric oxygenation prevented brain injury induced by hypoxia-ischemia in a neonatal rat model [J].
Calvert, JW ;
Yin, W ;
Patel, M ;
Badr, A ;
Mychaskiw, G ;
Parent, AD ;
Zhang, JH .
BRAIN RESEARCH, 2002, 951 (01) :1-8
[4]
Alpha-adrenoceptor subtypes [J].
Calzada, BC ;
De Artiñano, AA .
PHARMACOLOGICAL RESEARCH, 2001, 44 (03) :195-208
[5]
CHOI DW, 1990, PROG CLIN BIOL RES, V361, P291
[6]
CHOI DW, 1987, J NEUROSCI, V7, P357
[7]
Subtypes of functional α1- and α2-adrenoceptors [J].
Docherty, JR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 361 (01) :1-15
[8]
The effect of the α2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats [J].
Engelhard, K ;
Werner, C ;
Eberspächer, E ;
Bachl, M ;
Blobner, M ;
Hildt, E ;
Hutzler, P ;
Kochs, E .
ANESTHESIA AND ANALGESIA, 2003, 96 (02) :524-531
[9]
Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning [J].
Gidday, JM ;
Shah, AR ;
Maceren, RG ;
Wang, QO ;
Pelligrino, DA ;
Holtzman, DM ;
Park, TS .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (03) :331-340
[10]
GIOMBINI M, 2002, FISCHER RATS, V96, pA1290